Vunakizumab
Based on 1 Customer Validation
Vunakizumab (Anti-Human IL17A Recombinant Antibody) is a recombinant human IgGκ monoclonal antibody and an Interleukin-17A (IL-17A) inhibitor. Vunakizumab binds to IL-17A to inhibit downstream cytokines and block inflammatory signaling. Vunakizumab can be used for the research of chronic plaque psoriasis and ankylosing spondylitis.
For research use only. We do not sell to patients.
- Purity: 95.00%
- CAS No.: 1792181-33-9
- Molecular Weight:146.38 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Isotype
Human IgG1 kappa
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
[1]|
IL-17A |
In Vitro
In Vivo
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Gene ID
Accession
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
Human IgG1 kappa
Application
ELISA, FACS, Functional assay
Chemical Information
-
CAS No. 1792181-33-9
-
Appearance Liquid
-
Molecular Weight 146.38 kDa
-
Color Colorless to light yellow
-
SMILES
[Vunakizumab]
-
Synonyms
Anti-Human IL17A Recombinant Antibody; SHR-1314
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (256 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Vunakizumab
- 1792181-33-9
- Anti-Human IL17A Recombinant Antibody
- SHR-1314
- SHR1314
- SHR 1314
- SHR-1314
- Interleukin Related
- thyroid-associated ophthalmopathy
- CD34+ orbital fibroblasts
- chronic plaque psoriasis
- inflammatory signaling
- Interleukin-17A
- fibrosis
- adipogenesis
- human CD34+ orbital fibroblasts
- ankylosing spondylitis
- IL-17A
- Inhibitor
- inhibitor
- inhibit